 |
Research Director CNRS Contact: tangui.maurice(at)umontpellier.fr Phone: + 33/04 67 14 36 23 Group 2: Cellular determinants of neuroprotection |
NATIONAL Collaborations
- CNRS UMR 5088, Laboratoire d'Innovation Thérapeutique, Toulouse
- CNRS UMR 7200, Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération, Strasbourg
- CNRS UMR 5253, Ecole Nationale Supérieure de Chimie, Montpellier
- INRA UMR 866, Dynamique Musculaire et Métabolisme, Montpellier
- INSERM U 1051, Institut des Neurosciences de Montpellier, Montpellier
- INSERM U 1191, Institut de Génomique Fonctionnelle, Montpellier
- Société d'Accélération de Transfert de Technologie AxLR, Montpellier
INTERNATIONAL Collaborations
- Department of Histology, Faculty of Medical Sciences, Havana, Cuba
- Institute of Chemical Biology, Ilia State University, Tbilisi, Georgia
- Anavex Life Sciences, New York, USA
research
Tangui has spent more than 25 years in the field of neurosciences, including behavioral and molecular neuropharmacology, sigma receptors, neuropeptides, neurosteroids, neurotrophic factors, drug addiction, normal/pathological aging models including Alzheimer’s and related disorders, and behavioral phenotyping of rodent models. His publication records include 125 scientifc articles, 210 communications at national or international meeting, 5 patents and 35 invited conferences.
Tangui is CNRS Research Director since ten years and held research positions at Institut National de La Santé et de la Recherche Médicale (INSERM) U336, U710, U1198 and Centre National de la Recherche Scientifique (CNRS) UMR5102 in Montpellier. Tangui is a Chemical Engineer from ENSCM, by training. He holds a Ph.D. In cellular and molecular biology with a speciality in neuropharmacology from the university of Montpellier in 1990 and spent two years as a post-doc fellow in the Jouveinal Research Institute (Fresnes, France) and the Departments of Neuropsychopharmacology at Nagoya University Hospital and of Chemical Pharmacology at Meijo University (Nagoya, Japan). Tangui initiated the creation of a CRO company, Amylgen, and has several collaborations with industry, through regular contracts or scientific advisory boards. He was recipient of the bronze medal from CNRS.